dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp03523

General Description

Peptide name : KLAK peptide

Source/Organism : Not found

Linear/Cyclic : Linear

Chirality : D

Sequence Information

Sequence : KLAKLAKKLAKLAK

Peptide length: 14

C-terminal modification: Linear

N-terminal modification : Not found

Non-natural peptide information: None

Activity Information

Assay type : Internalization assay,Mitochondrial swelling assay,Cell-free apoptosis assay,Caspase activation assay

Assay time : 72h

Activity : LC50 : 387 μM

Cell line : KS1767

Cancer type : Not specified

Other activity : Not found

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 1523.9911 Dalton

Aliphatic index : 1.4

Instability index : -14.971

Hydrophobicity (GRAVY) : -0.071

Isoelectric point : 10.699

Charge (pH 7) : 5.7541

Aromaticity : 0

Molar extinction coefficient (cysteine, cystine): (0, 0)

Hydrophobic/hydrophilic ratio : 1.33333333

hydrophobic moment : -0.324

Missing amino acid : W,T,P,I,M,E,F,D,N,G,C,R,H,Q,S,Y,V

Most occurring amino acid : K

Most occurring amino acid frequency : 6

Least occurring amino acid : L

Least occurring amino acid frequency : 4

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (1, 0, 0.2)

SMILES Notation: CC(C)C[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)O

Secondary Structure :

Method Prediction
GOR HHHHHHHHHHHHHH
Chou-Fasman (CF) HHHHHHHHHHHCCC
Neural Network (NN) HHHHHHHHHHHHHH
Joint/Consensus HHHHHHHHHHHHHH

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 10470080

Uniprot : Not available

PDB : Not available

CancerPPD : Click here

ApIAPDB : Not available

CancerPPD2 ID : Not available

Reference

1 : Ellerby HM, et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med. 1999; 5:1032-8. doi: 10.1038/12469

Literature

Paper title : Anti-cancer activity of targeted pro-apoptotic peptides.

Doi : https://doi.org/10.1038/12469

Abstract : We have designed short peptides composed of two functional domains, one a tumor blood vessel 'homing' motif and the other a programmed cell death-inducing sequence, and synthesized them by simple peptide chemistry. The 'homing' domain was designed to guide the peptide to targeted cells and allow its internalization. The pro-apoptotic domain was designed to be nontoxic outside cells, but toxic when internalized into targeted cells by the disruption of mitochondrial membranes. Although our prototypes contain only 21 and 26 residues, they were selectively toxic to angiogenic endothelial cells and showed anti-cancer activity in mice. This approach may yield new therapeutic agents.